1. Stocks
  2. Aarti Drugs Ltd.
  3. Swot
swot-logo

Aarti Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Aarti Drugs Ltd. has 8 Strengths, 11 Weaknesses, 2 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Strong Performer, Under Radar Stocks (DVM)

Undervalued Growth Stocks

Companies with high TTM EPS Growth

PEG lower than Industry PEG

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Promoter decreasing their shareholding

Oversold by Money Flow Index (MFI)

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Decline in Quarterly Net Profit (YoY)

Declining profits every quarter for the past 2 quarters

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Brokers upgraded recommendation or target price in the past three months

FII / FPI or Institutions increasing their shareholding

Red Flags: Weakening Technicals and Share Price Decline

MFs decreased their shareholding last quarter

Red Flag: Companies seeing significant coronavirus impact

Bullish or Bearish Candlestick Strength - Indices

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Hammer (Bullish Reversal)